NCT02847624View on ClinicalTrials.gov

Post-Marketing Surveillance Study of Tolvaptan in Patients With ADPKD

CompletedOBSERVATIONAL
Enrollment

1,672

Participants

Timeline

Start Date

March 24, 2014

Primary Completion Date

September 20, 2022

Study Completion Date

September 20, 2022

Conditions
Polycystic Kidney, Autosomal Dominant
Interventions
DRUG

tolvaptan

Trial Locations (1)

Unknown

Otsuka Pharmaceutical Co., Ltd., Tokyo

Sponsors
All Listed Sponsors
lead

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY